INS and metabolic syndrome: An early study has shown that high doses of salicylates, a kind of Nonsteroidal anti-inflammatory drugs (NSAIDs) reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling [19].